156 related articles for article (PubMed ID: 32682485)
1. Androgen-receptor-positive hepatocellular carcinoma in a transgender teenager taking exogenous testosterone.
Lin AJ; Baranski T; Chaterjee D; Chapman W; Foltz G; Kim H
Lancet; 2020 Jul; 396(10245):198. PubMed ID: 32682485
[No Abstract] [Full Text] [Related]
2. Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status.
Aubrey C; Saad N; Köbel M; Mattatall F; Nelson G; Glaze S
Gynecol Oncol; 2021 May; 161(2):342-346. PubMed ID: 33663874
[TBL] [Abstract][Full Text] [Related]
3. Effects on Voice Fundamental Frequency and Satisfaction with Voice in Trans Men during Testosterone Treatment-A Longitudinal Study.
Nygren U; Nordenskjöld A; Arver S; Södersten M
J Voice; 2016 Nov; 30(6):766.e23-766.e34. PubMed ID: 26678122
[TBL] [Abstract][Full Text] [Related]
4. Sexual Reassignment Fails to Prevent Kennedy's Disease.
Lanman TA; Bakar D; Badders NM; Burke A; Kokkinis A; Shrader JA; Joe GO; Schindler AB; Bott LC; Harmison GG; Taylor JP; Fischbeck KH; Grunseich C
J Neuromuscul Dis; 2016 Mar; 3(1):121-125. PubMed ID: 27854206
[TBL] [Abstract][Full Text] [Related]
5. Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy.
Caanen MR; Soleman RS; Kuijper EA; Kreukels BP; De Roo C; Tilleman K; De Sutter P; van Trotsenburg MA; Broekmans FJ; Lambalk CB
Fertil Steril; 2015 May; 103(5):1340-5. PubMed ID: 25772768
[TBL] [Abstract][Full Text] [Related]
6. Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals.
Loverro G; Resta L; Dellino M; Edoardo DN; Cascarano MA; Loverro M; Mastrolia SA
Taiwan J Obstet Gynecol; 2016 Oct; 55(5):686-691. PubMed ID: 27751416
[TBL] [Abstract][Full Text] [Related]
7. Secondary pseudotumour cerebri in a patient undergoing sexual reassignment therapy.
Mowl AD; Grogg JA; Klein J
Clin Exp Optom; 2009 Sep; 92(5):449-53. PubMed ID: 19558530
[No Abstract] [Full Text] [Related]
8. ENDOCRINE TREATMENT OF GENDER-DYSPHORIC/GENDER-INCONGRUENT PERSONS: AN ENDOCRINE SOCIETY CLINICAL PRACTICE GUIDELINE.
Hembree WC; Cohen-Kettenis PT; Gooren L; Hannema SE; Meyer WJ; Murad MH; Rosenthal SM; Safer JD; Tangpricha V; T'Sjoen GG
Endocr Pract; 2017 Dec; 23(12):1437. PubMed ID: 29320642
[No Abstract] [Full Text] [Related]
9. Testosterone and Breast Cancer in Transmen: Case Reports, Review of the Literature, and Clinical Observation.
Tanini S; Fisher AD; Meattini I; Bianchi S; Ristori J; Maggi M; Lo Russo G
Clin Breast Cancer; 2019 Apr; 19(2):e271-e275. PubMed ID: 30655171
[No Abstract] [Full Text] [Related]
10. Cardiovascular disease in transgender people: recent research and emerging evidence.
Connelly PJ; Delles C
Cardiovasc Res; 2021 Dec; 117(14):e174-e176. PubMed ID: 34568899
[No Abstract] [Full Text] [Related]
11. TESTOSTERONE LEVELS ACHIEVED BY MEDICALLY TREATED TRANSGENDER WOMEN IN A UNITED STATES ENDOCRINOLOGY CLINIC COHORT.
Liang JJ; Jolly D; Chan KJ; Safer JD
Endocr Pract; 2018 Feb; 24(2):135-142. PubMed ID: 29144822
[TBL] [Abstract][Full Text] [Related]
12. Paediatrics: Transgender medicine--long-term outcomes from 'the Dutch model'.
Shumer DE; Spack NP
Nat Rev Urol; 2015 Jan; 12(1):12-3. PubMed ID: 25403246
[TBL] [Abstract][Full Text] [Related]
13. Superselective yttrium-90 radioembolization for hepatocellular carcinoma in high-risk cases: another tool in the toolbox.
Brown KT
J Vasc Interv Radiol; 2014 Jul; 25(7):1073-4. PubMed ID: 24968727
[No Abstract] [Full Text] [Related]
14. Intrahepatic arterial 90-yttrium resin spheres to treat liver cancer.
Grady ED
Int J Nucl Med Biol; 1978; 5(6):253-4. PubMed ID: 216648
[No Abstract] [Full Text] [Related]
15. Endometrial Cancer in a Transgender Man with Prolonged Exogenous Testosterone Use.
Gill S; Anderson M; Neveu J
Obstet Gynecol; 2024 Apr; 143(4):e125-e128. PubMed ID: 38330401
[TBL] [Abstract][Full Text] [Related]
16. Care of a Transgender Adolescent.
Klein DA; Ellzy JA; Olson J
Am Fam Physician; 2015 Jul; 92(2):142-8. PubMed ID: 26176373
[No Abstract] [Full Text] [Related]
17. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
Dawson LA
J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
[No Abstract] [Full Text] [Related]
18. Impact of Exogenous Testosterone on Reproduction in Transgender Men.
Moravek MB; Kinnear HM; George J; Batchelor J; Shikanov A; Padmanabhan V; Randolph JF
Endocrinology; 2020 Mar; 161(3):. PubMed ID: 32105330
[TBL] [Abstract][Full Text] [Related]
19. [Transgender, transsexualism and gender dysphoria: current developments in diagnostics and health care].
Nieder TO; Briken P; Richter-Appelt H
Psychother Psychosom Med Psychol; 2014 Jun; 64(6):232-45. PubMed ID: 24892869
[No Abstract] [Full Text] [Related]
20. Care of the Transgender Patient.
Safer JD; Tangpricha V
Ann Intern Med; 2019 Jul; 171(1):ITC1-ITC16. PubMed ID: 31261405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
